Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Total of all costs and expenses
3Y CAGR
+44.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.06M | +33.7% |
| 2024 | $50.89M | -23.0% |
| 2023 | $66.08M | +190.8% |
| 2022 | $22.72M | -20.7% |
| 2021 | $28.65M | - |